Convertible Note Payable (Details)																									12 Months Ended
Convertible Note Payable (Details)	Dec. 11, 2024 shares	Dec. 09, 2024 USD ($) $ / shares shares	Nov. 04, 2024 USD ($) $ / shares shares	Oct. 02, 2024 shares	Oct. 01, 2024 USD ($) $ / shares shares	Sep. 12, 2024 shares	Sep. 11, 2024 USD ($) $ / shares	Jun. 17, 2024 USD ($) $ / shares shares	May 23, 2024 USD ($)	May 21, 2024 shares	May 20, 2024 USD ($) $ / shares	Apr. 19, 2024 shares	Apr. 17, 2024 USD ($) $ / shares	Apr. 03, 2024 shares	Apr. 02, 2024 USD ($) $ / shares	Feb. 21, 2024 shares	Feb. 16, 2024 USD ($) $ / shares	Feb. 05, 2024 shares	Feb. 01, 2024 USD ($) $ / shares	Jan. 16, 2024 shares	Jan. 11, 2024 USD ($) $ / shares	Apr. 13, 2023 USD ($)	Apr. 19, 2022 $ / shares	Nov. 19, 2021 $ / shares	Dec. 31, 2025 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) shares
Convertible Note Payable [line Items]
Note and accrued interest																						2.00%
Number of trading days			10 days		10 days		10 days	10 days			10 days		10 days		10 days		10 days		10 days		10 days	10 days			10 days
Extension fee									2.00%
Outstanding balance of extension fee (in Dollars)									$ 10,934
Convertible notes payable, interest rate per annum																									3.30%
Interest rate per annum upon default in repayment of debt																									22.00%
Redeem of outstanding note (in Dollars)																									$ 500,000
Debt instrument redemption price percentage		82.00%	82.00%		82.00%		82.00%	82.00%			82.00%		82.00%		82.00%		82.00%		82.00%		82.00%
Interest expense (in Dollars)																									$ 32,237
Stock issued during period shares (in Shares) \| shares		81,576	69,687		69,687	69,687		70,192		59,079		54,074		51,245		40,817		40,269		38,023
Convertible Notes [Member]
Convertible Note Payable [line Items]
Debt extension fee (in Dollars)																						$ 65,639
Number of trading days		10 days	10 days
Note converted into common stock																							70,000	176,229
Conversion price (in Dollars per share) \| $ / shares		$ 0.1435	$ 0.1435		$ 0.1435		$ 0.1435	$ 0.2137			$ 0.2539		$ 0.2774		$ 0.2927		$ 0.3675		$ 0.3725		$ 0.3945			$ 29.79085	$ 150
Convertible notes payable, interest rate per annum																									5.00%
Debt instrument redemption price percentage		82.00%	82.00%		82.00%		82.00%	82.00%			82.00%		82.00%		82.00%		82.00%		82.00%		82.00%				82.00%
Interest expense (in Dollars)																									$ 0	$ 29,088
Debt redemption amount (in Dollars)		$ 117,060	$ 100,000		$ 100,000		$ 100,000	$ 150,000			$ 150,000		$ 150,000		$ 150,000		$ 150,000		$ 150,000		$ 150,000
China Pharma’s [Member] \| Convertible Notes [Member]
Convertible Note Payable [line Items]
Note converted into common stock																									35,000
Minimum [Member]
Convertible Note Payable [line Items]
Redemption amount (in Dollars)									150,000
Percentage increase on outstanding debt for default																									5.00%
Minimum [Member] \| Convertible Notes [Member]
Convertible Note Payable [line Items]
Debt redemptions weighted average price																						85.00%
Maximum [Member]
Convertible Note Payable [line Items]
Redemption amount (in Dollars)									$ 37,182.33
Percentage increase on outstanding debt for default																									15.00%
Maximum [Member] \| Convertible Notes [Member]
Convertible Note Payable [line Items]
Debt redemptions weighted average price																						82.00%
Common Stock [Member]
Convertible Note Payable [line Items]
Stock issued during period shares (in Shares) \| shares	815,746		696,864	696,864		696,864		701,918		590,783		540,735		512,470		408,164		402,685		380,228					12,260,000	1,465,000
Common Stock [Member] \| China Pharma’s [Member] \| Convertible Notes [Member]
Convertible Note Payable [line Items]
Conversion price (in Dollars per share) \| $ / shares																							$ 75

CHINA PHARMA HOLDINGS, INC. 10-K